
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma | NEJM
Nov 24, 2005 · Neuroblastoma is a childhood cancer with considerable morbidity and mortality. Tumor-derived biomarkers may improve risk stratification. We screened 915 samples of …
Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma ...
Sep 30, 2010 · The current study shows that the majority of infants and some children who have advanced neuroblastoma without MYCN amplification can be cured with substantially reduced …
Chromosome 6p22 Locus Associated with Clinically Aggressive ...
Jun 12, 2008 · We observed a significant association between neuroblastoma and the common minor alleles of three consecutive single-nucleotide polymorphisms (SNPs) at chromosome …
MYCN mediates cysteine addiction and sensitizes neuroblastoma …
Apr 28, 2022 · Here we show that MYCN induces massive lipid peroxidation on depletion of cysteine, the rate-limiting amino acid for glutathione (GSH) biosynthesis, and sensitizes cells …
Molecular Mechanisms of MYCN Dysregulation in Cancers
MYCN, a member of MYC proto-oncogene family, encodes a basic helix-loop-helix transcription factor N-MYC. Abnormal expression of N-MYC is correlated with high-risk cancers and poor …
MYCN in neuroblastoma: The kings' new clothes and drugs
Dec 1, 2024 · New findings show that MYC proteins have novel oncogenic functions that are tumor-promoting and go beyond the regulation of gene expression.
MYCN Function in Neuroblastoma Development - PubMed
Jan 27, 2021 · Dysregulated expression of the transcription factor MYCN is frequently detected in nervous system tumors such as childhood neuroblastoma. Here, gene amplification of …
Retinoblastoma Origins and Destinations | New England Journal of Medicine
Apr 17, 2024 · In MYCNA tumors, the extremely high MYCN level promotes glycolytic metabolism, a feature that is important for cancer cell growth as well as for the maintenance …
MYCN Drives a Tumor Immunosuppressive Environment Which …
Feb 25, 2021 · Our work investigated in details the relationship of MYCN with the immune system, finding a correlated immune-suppressive phenotype in neuroblastoma (NB) and different …
MYCN in human development and diseases - PMC
Somatic mutations in MYCN have been identified across various tumors, playing pivotal roles in tumorigenesis, tumor progression, and unfavorable prognoses. Despite its established …